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Development and validation of sandwich quantitative ELISA prototype
based on the bovine IFNg for the detection of cellular immunity
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Abstract: Immunodiagnostic tests based on in vitro enzymatic methods are mostly preferred to in vivo methods for the detection
of cellular immunity due to their cost, applicability, repeatability, and higher sensitivity. Therefore, the development of a quantitative
sandwich ELISA prototype detecting bovine IFNg (bIFNg) was planned. In this study, two clone originated monoclonal antibodies
were used for capturing the plates, and biotin conjugated monoclonal Ab was used as a secondary antibody in sandwich ELISA.
Different approaches such as inter- and intraassay precision and dilution parallelism were evaluated for test validation. The correlation
of coefficient variation that is over 95% and 5% variations in precision detection, with an estimated concentration of 98.7%, makes
this prototype an alternative test for detection and quantitation of bIFNg. Trials intending to detect the shelf-life of the prototype
for 6 months demonstrated that the detection limit was found to be approximately 100 pg/mL of the capturing Ab from clone I with
a detection range of 10% CV throughout that period. Preliminary results show that the prototype can be applied to in vitro bovine
tuberculosis detection for plasma samples at least for the validation period of 6 months.
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1. Introduction
Tests based on classical cultural methods and the
amplification of specific genes by polymerase chain
reaction (PCR) are not sufficient for the diagnostics of
some clinical and subclinical intracellular infections.
Immunological methods detecting the cellular immunity
are also required for diagnosis. These types of in vivo and
in vitro cellular tests are based on cytokines produced
specifically by these types of immune responses or reactions
to antigens in tissues. In vitro applications are preferred
to the counterpart in vivo tests for their higher sensitivity
at the initial stage of infection and their repeatability,
availability, and applicability to a variety of antigens. They
are also better in terms of logistic facilities and shorter test
intervals (shorter desensitization time). Therefore, in vitro
applications are utilized in the detection of tuberculosis
(TB) and paratuberculosis (1–5). Different enzyme linked
immunosorbent assay (ELISA) models are implemented
for the development of a sandwich quantitative ELISA
(qELISA) for measuring proteins or cytokines (6–8).
Although the skin test is still widely used as a clinical
indicator for evidence of previous or active tuberculosis
infection in vivo, the European Union authorized a test
* Correspondence: ogenc@omu.edu.tr
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known as Bovigam in vitro in 2002, and the test received
approval by the USDA as an ancillary test in the US bovine
TB surveillance program in 2003 (9,10). Since then it has
been successfully adopted in Australia, New Zealand,
South America, and Asia (7,9).
Cellular immunity can also be monitored in vitro either
by cytokine release tests such as IFNg sandwich ELISA
or by lymphoproliferation test based on a radioactive
substance (11–13). There are a variety of commercial
kits and protocols that are able to detect IFN gamma
induced by specific protein antigens, especially for the
detection of TB, brucellosis, paratuberculosis, and various
parasitic and viral infections (2–4,7,14). Problems with the
availability of these kits, their cost, and the requirement of
standardization of the test for each event led us to develop
the sandwich qELISA.
In this study, the production and the validation of
the sandwich qELISA prototype were designed as an
ancillary diagnostic test to be used for tuberculosis
infections. Therefore, two kinds of monoclonal antibodies
out of 5 commercially available ones with different clone
origins and different ELISA reagents were used for the
development of the quantitative sandwich ELISA to
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measure IFN gamma quantity. In the study, performance
characteristics and stability tests of the prototype were
performed and validation studies were completed with
bovine TB confirmed plasma samples.
2. Materials and methods
2.1. Induction of blood cells and separation of plasma
Plasma samples used in this study were obtained from
tuberculosis-suspicious blood samples and healthy calves.
The induction and separation of plasma were performed in
accordance with the instructions of Bovigam tuberculosis
detection kit as follows. Initially, blood samples in heparincontaining tubes were transferred to cell-culture plates and
then PBS, avian PPD, and bovine PPD were added. The
mixture was incubated at 37 °C in 5% CO2 incubator for 18
h to stimulate lymphocytes to produce IFNg. In addition
to PPDs, Concanavalin A (ConA, Sigma C5275) was
used as a mitogenic stimulator. Plasma samples separated
from blood were used for detection of tuberculosis using
the commercial ELISA kit (Bovigam), and then stored in
the freezer until use. In the second stage, IFNg detection
was tested using the sandwich ELISA as suggested by
the manufacturer. Different criteria were used for the
interpretation of the test results due to the difference and
proportion of OD values in bovine, avian, and control
samples (7). Results were interpreted as positive when OD
values of bovine PPD-nil antigen and bovine PPD-avian
PPD were found ≥0.1, and as negative when differences
were ≤0.1 (9). Plasma samples induced with bovine
PPD and found positive were used for detection of IFNg
quantitation for the development of the prototype.
2.2. IFNg sandwich quantitative ELISA
In this study, modifications recommended by Rothel et al.
(6), Rue-Domenech et al. (7), and Genç et al. (8) were used
for the development of sandwich qELISA for measuring
bIFNg in plasma and sera. Sandwich ELISA assays based
on 2 types of conjugates and monoclonal antibodies were
used to determine the IFNg quantity in plasma and sera;
blocking buffer was the control. For this purpose, mouse
monoclonal antibodies of bIFNg, originated from two
different clones (bIFNg-I, Mabtech and CC302, Thermo),
were used as primary antibodies and were absorbed to the
wells of ELISA plates (Immulon, 2HB) at a concentration
of 2 μg/mL in coating buffer (1X PBS, pH 7.4). After
overnight incubation at 4 °C, the plates were blocked
with 0.1% bovine serum albumin (BSA, Sigma) in 1X PBS
(pH 7.4) for 1 h at 37 °C. The plates were washed three
times with 50 mM Tris- HCl containing 0.05% Tween 20
(pH 7.0–7.4). Standard r-bIFNg (Thermo, RBOIFNGI,
MF158073) was added into the reagents (blocking buffer,
plasma, and sera) at different concentrations as triplicate
and incubated for 2 h at 37 °C. After the plates were washed
three times, biotinylated anti-mouse bIFNg (Mabtech,

PAN-biotin) was added at a concentration of 0.5 µg/mL
as secondary antibodies. After 1 h of incubation at 37 °C,
the plates were washed, and streptavidin conjugates with
alkaline phosphatase (AP) (Sigma, S2890) and horse radish
peroxidase (Sigma, S2438) were added to the wells and the
plates were incubated at 37 °C for 1 h. Following washing,
pNPP substrate (Amresco) solution for AP conjugate and
OPD (Calbiochem, 523120) solution for PO conjugate
were added and the plates were incubated for 60 min. The
reaction colors were measured using a microplate reader
(Thermo, Multiscan EX). The concentration of bIFNg was
calculated using a linear-regression equation obtained
from the absorbance values of the standards (R2 > 0.95).
In addition to test optimization, validation trials, assay
precisions, detection limit comparisons, and shelf-life
testing of the prototype were performed.
2.2.1. Validation of qELISA in the blocking solution,
plasma, and serum samples
The evaluations of quantitation of recombinant bIFNg
(r-bIFNg) in the blocking buffer, plasma, and serum
samples were performed in the same plate. Results were
expressed as pg/mL for specifying IFNg concentrations
and the detection limit in samples.
2.2.2. Assay precisions
A standard curve was created on each plate by linear
regression calculations with respect to the bIFNg standard
calibrator in the blocking buffer, plasma, and serum
samples. The results of the inter- and intraassays were
interpreted after obtaining a regression value of R2 > 0.95.
2.2.2.1. Interassay precision
Five different concentrations (50, 62.5, 125, 250, and 500
pg/mL) of reference r-bIFNg were evaluated in 5 separate
plates in 4 repeats using blocking buffer, sera, and plasma.
The coefficient of variation of each sample was calculated
at 5 concentrations in the blocking buffer.
2.2.2.2. Intraassay precision
Each test, using 6 samples in 6 replicates, was performed
to determine the coefficient of variation in two plates with
10–1000 pg/mL (10, 50, 100, 200, 400, and 1000 pg/mL)
concentrations.
2.3. IFNg quantity with the confirmed plasma samples
In the study, sandwich qELISA was applied for the detection
of IFNg quantity in plasma samples that were confirmed
by Bovigam detection kit. For this purpose, a total of 122
plasma samples consisting of 72 tuberculosis positive and
50 tuberculosis negative samples were evaluated in terms
of IFNg quantity. The results of the sandwich qELISA are
presented in Table 1.
2.4. Dilution parallelism
Recombinant bIFNg in four samples within the range of
50–400 pg/mL was diluted at serial 2-fold dilutions, from
1:4 to 1:16, to ensure the recovery rate of IFNg (Table 2).
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2.5. Shelf-life testing
Plates coated with clone I originated mAb blocked with
BSA were packed with aluminum foil with desiccant and
incubated at 4 °C for a period of 6 months. After the
blocking step, 10 freshly coated qELISA plates and 15 out
of the 50 IFNg coated plates kept at 4 °C were evaluated
for 6 months. Mean OD and CV (%) comparisons of the
sandwich qELISA based on different concentrations of
bIFNg (100–800 pg/mL) were performed with freshly
prepared ELISA prototypes for various time periods of 1,3,
and 6 months (Table 3).
2.6. Statistics
Regression values and correlation coefficients were
calculated, and comparisons of percentages and CVs were
done with MedCalc-version 15.2.2 (http://www.medcalc.
org).
3. Results
3.1. Quantitative enzyme linked immunosorbent assay
The results were 100% compatible with those of Bovigam,
when the detection limit was evaluated as the cut-off value.
All 50 positive plasma samples (50/72, 69.4%) approved
with Bovigam tuberculosis test were found to contain over
5 ng/mL IFNg with the primary monoclonal antibody of
the clone CC302. However, the detection limit with the
primary antibody of clone I was determined as 100 pg/mL
and it was evaluated as sensitive. The IFNg quantity results
of 72 positive and 50 negative plasma samples are shown
in Table 1.
3.1.1. Validation of qELISA with plasma and sera
Fifty negative and 72 positive plasma samples as detected
by sandwich ELISA (Bovigam) were found compatible in
100% and 69.4%, respectively, with the antibodies of clone

I and clone CC302 when the cut-off point was accepted
as the detection limit. However, as clone I based qELISA
has a cut-off value of 100 pg/mL, all 72 positive plasma
samples were detected in different concentrations in a
range of 125 pg/mL to 5 ng/mL. When a comparison of
the detection limit was performed in connection with
bIFNg in the blocking buffer, plasma, and serum samples,
the blocking solution was significantly different (P < 0.05)
from the other samples. The detection limit of bIFNg in
the blocking solution was 50 pg/mL, but it was 100 pg/
mL in both plasma and serum. Besides, the inhibitions
were determined mostly in serum, but it did not make any
difference in the detection limit (P > 0.05). The prototypes
were tested in order to determine inter- and intraassay
precision of the test for validation trials. Comparisons
with both inter- and intraassay tests indicated a less than
5% coefficient of variation.
3.1.2. Sensitivity of the test
The lowest concentration of the test was detected as 100
pg/mL in plasma and sera and was used as the cut-off
value throughout the test. At the same time, OD values
of the negative controls were obtained with lower limits
of 10–50 pg of r-bIFNg, so these values were accepted out
of the detectable range. As the detection limits of plasma
and sera were found to be 100 pg/mL, the concentration
of r-bIFNg in negative samples was <100 pg/mL; this
was concordant (90%, 45/50) with the negative samples
obtained from tuberculosis free samples shown in Table 1.
3.1.3. Intraassay and interassay comparisons
The average coefficient of variation was less than 5%
for each concentration within the detection limits. In
interassay comparisons, the mean CV results of less than
5% were determined similar to the results in the intraassay
studies (not illustrated).

Table 1. Sensitivity, specificity, accuracy, and detection range of the sandwich qELISA based on two primary antibodies with different
clone origins.
Sandwich qELISA tests with two
different primary Abs

Clone I

Clone CC302

positive (n = 77)

Bovigam ELISA
positive (n = 72)

negative (n = 50)

50 (>5 ng)*

5 (<500 pg)*

Sensitivity

Specificity

Accuracy

100

90

95.9

12 (125–500 pg) *
10 (125 pg) *

negative (n = 45)

0

45 (<100 pg)*

positive (n = 50)

50 (>5 ng)**

0

negative (n = 72)

22 (<5 ng)**

50 (<5 ng)**

69.4

100

82

A total of 122 plasma samples tested by Bovigam ELISA were used for comparison of the assays performed with clone I and clone CC302
monoclonal antibodies. *: plasma concentrations measured by clone I, and **: clone CC302 based ELISAs.
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3.1.4. Recovery rates
In the study, the recovery rates ranged from 80% to 116%,
with an overall recovery of 98.7% (Table 2).
3.1.5. Shelf-life testing
As a result, 25 plates absorbed with clone I originated
monoclonal antibodies were used for detection limit
comparisons for up to 6 months. The lowest detection limit
was 50 pg/mL for the blocking solution, and 100 pg/mL for
the plasma and sera samples. The study for determining
the shelf-life of the prototype showed that IFNg could be
detectable in both blocking and plasma samples for up to
3 months with 5% CV, and for 6 months with 10% CV in
plates stored at 4 °C.
4. Discussion
Particularly for intracellular infections, diagnoses based
on standard tests are not sufficient. Therefore, improved
immunodiagnostic methods for detection of cellular
immunity are necessary. In vitro applications are preferred
to in vivo assays for their higher sensitivity, repeatability,
availability and applicability to different antigens. They
are also better in terms of logistic facilities and shorter
test intervals (1,7,9). A major breakthrough has been
the development of in vitro assays that measure T cell
release of IFNg, which have become an alternative to the
tuberculin skin test (1,15,16).
The bIFNg test is a well-established method for
diagnosis of bovine tuberculosis with a sensitivity of 95.2%
(7) and has been used in parallel with the tuberculin skin
test in eradication programs (17). It was also demonstrated
that the test is able to identify naturally infected but skintest negative animals (18). Therefore, we aimed to develop

a sandwich ELISA for the detection of IFNg response
quantitatively in bovine whole blood samples based on
commercial antibody reagents. For this purpose, the
accuracy and test performance were evaluated using
confirmed plasma samples. In this study, only bovine
PPD positive plasma samples that were confirmed by
Bovigam were used for the measurement of IFNg content.
Therefore, 72 positive and 50 negative plasma samples as
detected by Bovigam IFNg ELISA were tested for bIFNg
content in comparison with the control negative and
positive samples for each test. The results showed that
IFNg can be detectable in plasma at least at a 125 pg/mL
concentration with the use of PPD antigens. As the test was
evaluated with different concentrations (not illustrated)
and dilutions (Table 2) of r-bIFNg, it was evident that the
prototype could detect IFNg in 50, 100, and 100 pg/mL in
blocking solutions, plasma and sera, respectively.
In this study, the bIFNg ELISA results with primary
antibodies of clone I originated monoclonal antibodies
were found sensitive (100%) and accurate (95.9%), but
less specific (90%) than those of clone CC302 (Table 1)
Therefore, a prototype prepared with clone I originated
primary Ab was evaluated for determination of shelflife. Although the results are satisfactory, a reevaluation
with more samples representing tuberculosis status is still
needed for this prototype.
Antigen specific stimulation of IFNg production
was utilized as a diagnostic tool for the detection of M.
bovis and M. paratuberculosis in cattle (11,18). With this
in mind, we designed the present study to evaluate the
efficacy of the whole blood home-made bIFNg assay as a
detection tool, and also to get some information on the

Table 2. The impact of dilutions on the recovery rate of r-bIFNg in the blocking solution.
Sample no.

Dilution rate

Expected (pg/mL)

Observed (pg/mL)

Recovery of
r-bIFNg (%)

Mean recovery (%)

1

1:4
1:8
1:16

200
100
50

185
98
58

92.5
98
116

102.2

2

1:4
1:8
1:16

200
100
50

206
94
40

103
94
80

92.3

3

1:4
1:8
1:16

400
200
100

386
207
105

96.5
103.5
105

101.7

4

1:4
1:8
1:16

400
200
100

405
194
98

101.25
97
98

98.75

Recombinant bIFNg was diluted at different concentrations with the range of 50–400 pg/mL for detection of the recovery rate of r-bIFNg.
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Table 3. Mean OD and CV values of the clone I based qELISA prototype for the detection of shelf life in comparison with simultaneously
prepared fresh samples.
Incubation time and number of ELISA plates
IFNg conc.
Plasma (pg/mL)
800

fresh samples, n: 10
Mean OD ±
CV(%)
± SD
3.38 ± 0.17
5.04

1 mo, n: 5
MCV(%) Mean OD ± SD CV(%) MCV(%)

3.8

3.39 ± 0.13

3 mo, n: 5

3.89

Mean OD ± SD CV(%)
3.38 ± 0.15

MCV(%) Mean OD ± SD CV(%)

4.41

3.49 ± 0.32

400

2.39 ± 0.11

4.25

2.40 ± 0.12

5.16

2.40 ± 0.13

5.20

2.48 ± 0.24

9.85

1.53 ± 0.04

2.45

1.60 ± 0.07

4.75

1.56 ± 0.08

4.86

1.50 ± 0.16

10.48

100

0.77 ± 0.03

3.40

0.79 ± 0.04

4.58

0.80 ± 0.04

4.68

0.81 ± 0.10

12.57

Blocking sol.
(pg/mL)

Mean OD ± SD CV(%)

800

3.36 ± 0.11

3.45

2.39 ± 0.08

3.39

200

1.61 ± 0.02

100

0.75 ± 0.02

MCV(%) Mean OD ± SD CV(%) MCV(%)
3.31 ± 0.17

5.10

2.41 ± 0.11

4.41

1.72

1.60 ± 0.08

2.66

0.80 ± 0.04

2.8

Mean OD ± SD CV(%)
3.43 ± 0.16

4.75

2.47 ± 0.13

5.29

4.68

1.47 ± 0.08

4.99

0.81 ± 0.05

4.8

4.8

MCV(%) Mean OD ± SD CV(%)
3.49 ± 0.28

8.05

2.45 ± 0.24

9.64

5.61

1.50 ± 0.16

10.4

6.74

0.81 ± 0.11

13.5

5.6

MCV(%)

9.41

200

400

4.6

6 mo, n: 5

10.6

MCV(%)

10.4

Mean OD and CV (%) comparisons of sandwich qELISA prototype based on different concentrations of bIFNg (100-800 pg/mL) in plasma and blocking solution for various
time periods of 1,3 and 6 months.
n: the number of plates, mo: month, OD: optical density, CV: coefficient of variation, MCV: mean of CV

IFNg quantity of the evaluated plasma samples that were
induced with bovine and avian PPD antigens. There is no
precise information on IFNg levels in bovine TB and/or
paraTB infected animals, but the detection limit of qELISA
measuring IFNg concentrations is about 50–2000 pg/mL.
As the animals sensitized with the agent can be detectable
within that range, an evaluation of the test results can be
performed according to the difference or the proportion
of OD values of IFNg in plasma samples induced with a
specific protein antigen. But some researchers consider
IFNg levels instead of OD value interpretation. Mikkelsen
et al. (19) confirmed positive paraTB in PPD johnin
stimulated samples with IFNg concentration ≥1 ng/mL
when interpreting the results. In our study, confirmed
plasma samples stimulated with bovine PPD were evaluated
and the results were categorized at a range of 100–1000 pg/
mL concentrations. This classification, whether depending
on concentration detection or on OD value interpretation,
is not strict.
It can be concluded that our home-made prototype
can be used for 6 months with 5% variations in precision
detection and dilution parallelism with overall recovery
rate of 98.7%. In addition, shelf-life studies showed that the
prototype can detect bIFNg at a concentration of 100–800
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